Born from AI safety research, RLHF has become an important product innovation in its own right. It’s the “secret sauce” making conversational agents from Cohere, OpenAI, and Anthropic so conversant.
Humanity is now one step closer to realizing Star Trek-esque technology – 3D printing tissue patches to replace impaired biological functions and cure disease.
In this week’s Radical Reads, we explore the most significant takeaways for industries looking to integrate AI into their operations.
Aaron Rosenberg, previous Head of Strategy & Operations at DeepMind, joined as a Partner at Radical Ventures, based in London.
Performing well across tasks is difficult, as is benchmarking these models’ performance. Performance tends to vary depending on the task at hand. How can we determine if a model is “better” than another?
While the broader venture investing market has significantly contracted over the last year, it seems that everyone is trying to invest in “generative AI” companies these days…
When founders start a company, they know the risks they are taking on. They understand that they are turning down the opportunity to work at secure jobs with predictable income…
Biology and medicine are filled with problems that humans find challenging, or impossible, to solve. Take, for example, the protein folding problem…
AI has burst into the mainstream. But despite the hype, companies are still grappling with how best to understand this technology and its enormous potential.
What you won’t see behind the slick UI of ChatGPT is the gigantic mess of infrastructure that’s needed to make it tick…
Get our weekly email newsletter of curated insights and AI news.
© 2023 Radical Ventures Investments Inc.